L'Oréal SA has prepared its financial statements in accordance with the new Regulation ANC 2022-06 on the modernisation of financial statements, amending Regulation ANC 2014-03. The new regulation, effective 1 January 2025, sets out to modernise, simplify and clarify the presentation of financial statements. It:
Where necessary, the impact of this new regulation has been described in the relevant notes.
L’Oréal Groupe announced on 3 February 2025 the signing of an agreement for the sale of approximately 29.6 million Sanofi shares, i.e. 2.14% of the share capital, to Sanofi at a price of €101.5 per share, i.e., a total consideration of €3 billion. The resulting €2,992.8 million net capital gain was recognised in non-recurring items. Following completion of the transaction and cancellation of the shares bought back, L’Oréal now holds 7.2% of Sanofi’s share capital and 13.1% of the voting rights (see notes 8 and 31).
On 13 May 2025, L'Oréal Groupe successfully completed its first bond issue on the US market, for a total nominal amount of USD 1 billion. The bonds issued have a 10-year maturity and pay a coupon of 5.00% per annum.
On 12 November 2025, L’Oréal placed a dual tranche bond offering for a total nominal amount of €3 billion (see note 19).
The French Finance Act of 14 February 2025 introduced an exceptional levy on the profits of large companies (Article 48). For 2025, this new levy applies to companies subject to corporate income tax generating sales of €1 billion or more in France, and is calculated based on the average taxable profit for financial years 2024 and 2025. As a result, L'Oréal SA recognised an income tax charge of €142.4 million in 2025.
